المؤلفون: Reem Kashlan, Iltefat H. Hamzavi, Alexis B. Lyons, Shanthi Narla

المصدر: JAAD Case Reports, Vol 8, Iss, Pp 77-79 (2021)
JAAD Case Reports

مصطلحات موضوعية: medicine.medical_specialty, business.industry, HS, hidradenitis suppurativa, hidradenitis suppurativa, Case Report, Biosimilar, ADA, antidrug antibodies, Dermatology, lcsh:RL1-803, infusion reaction, medicine.disease, IFX, infliximab, Infliximab, lcsh:Dermatology, medicine, Hidradenitis suppurativa, biosimilar, Infusion reaction, infliximab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3c47ea97f1da733e1a7bebdff3a07f8Test
https://doi.org/10.1016/j.jdcr.2020.12.011Test

المؤلفون: Shweta Urva, Julie S. Moyers, Krister Bokvist, Kyle W. Sloop, Jorge Alsina-Fernandez, William C. Roell, Charles Benson, Uma Kuchibhotla, David A. D'Alessio, Corina Loghin, Xuewei Cui, Tamer Coskun, Over Cabrera, Daniel A. Briere, Ruth E. Gimeno, Axel Haupt

المصدر: Molecular Metabolism
Molecular Metabolism, Vol 18, Iss, Pp 3-14 (2018)

مصطلحات موضوعية: 0301 basic medicine, ipGTT, Intraperitoneal glucose tolerance test, LY3298176, ADA, Antidrug antibodies, Receptor agonist activity, Pharmacology, 0302 clinical medicine, Glucagon-Like Peptide 1, Medicine, OGTT, Oral glucose tolerance test, Receptor, T2DM, Type 2 diabetes mellitus, CNS, Central nervous system, ECG, Electrocardiogram, SMBG, Self-monitored blood glucose, Glucagon-like peptide-1, SAD, Single-ascending dose, LY, LY3298176, Original Article, medicine.drug, Agonist, POC, Proof-of-concept, lcsh:Internal medicine, Glucose-dependent insulinotropic polypeptide, medicine.drug_class, Incretin, 030209 endocrinology & metabolism, GLP-1 RA, Glucagon-like peptide-1 receptor agonist, Incretins, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Metabolic Diseases, PL, PPlacebo, Diabetes mellitus, Type 2 diabetes mellitus, Humans, DU, Dulaglutide, Obesity, GIP, Glucose-dependent insulinotropic polypeptide, lcsh:RC31-1245, Molecular Biology, MAD, Multiple-ascending dose, Glucagon-like peptide 1 receptor, business.industry, CI, Confidence interval, Cell Biology, medicine.disease, DIO, Diet-induced obesity, 030104 developmental biology, HS, Healthy subjects, Diabetes Mellitus, Type 2, MMRM, Mixed model for repeated measures, Dulaglutide, business, LSM, Least square mean

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ca485dc3a86e98e8a5c2fbb364cd27Test
http://europepmc.org/articles/PMC6308032Test

المؤلفون: Ali Alsharqi, R Parslew, Prativa S. A. Jayasekera

المصدر: JAAD Case Reports

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Case Report, Dermatology, PASI, Psoriasis Area and Severity Index, ustekinumab, Etanercept, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Psoriasis Area and Severity Index, Psoriasis, Internal medicine, Ustekinumab, medicine, Adalimumab, Survival rate, 030203 arthritis & rheumatology, business.industry, DLQI, Dermatology Life Quality Index, psoriasis, ADA, antidrug antibodies, medicine.disease, Infliximab, biological therapy, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ba3a48e87281c8a335fed0c800e9394Test